Brief: Seelos Therapeutics Receives Acknowledgement Letter Of A Clinical Trial Notification From Australian Government
08/03/2022 13:23
March 8 (Reuters) - Seelos Therapeutics Inc SEEL.O :
* SEELOS THERAPEUTICS RECEIVES AN ACKNOWLEDGEMENT LETTER OF A CLINICAL TRIAL
NOTIFICATION FROM THE AUSTRALIAN GOVERNMENT DEPARTMENT OF HEALTH THERAPEUTIC
GOODS ADMINISTRATION FOR A PILOT STUDY OF SLS-005 IN ALZHEIMER'S DISEASE
Source text for Eikon: ID:nPn8scJQ8a
Further company coverage: SEEL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Seelos Therapeutics
See all newsBrief: Seelos Therapeutics Commences Chapter 11 Proceedings- Court Filing
Brief: Seelos Therapeutics Announces Notice Of Delisting From Nasdaq And Transfer Of Listing To Over-The-Counter Market
Brief: Seelos Announces Postponement Of Its Annual Meeting Of Stockholders
Brief: Seelos Therapeutics Announces 1-For-16 Reverse Stock Split
U.S. STOCKS ON THE MOVE-Copper miners, Visa, Bluebird bio